title: Prognosis of oocyte donation cycles: a prospective comparison of the in vitro fertilization-embryo transfer cycles of recipients who used shared oocytes versus those who used altruistic donors.
abstract: OBJECTIVE
  To prospectively compare the prognosis of IVF-ET cycles using oocyte sharing vs. cycles using altruistic donors.
  
  
  METHODS
  Prospective cohort prognostic study.
  
  
  METHODS
  University teaching hospital.
  
  
  METHODS
  A total of 353 consecutive infertile women with premature ovarian failure or diminished ovarian function.
  
  
  METHODS
  After receipt of institutional ethics approval, IVF-ET was performed with the use of either oocyte sharing (n = 220) or altruistic donors (n = 133). Continuous data (mean + SD [95% confidence interval]) were compared with Student's t test or Mann-Whitney test as appropriate; categoric data were compared with Fisher's exact test, odds ratios (OR), and relative risk (RR). Two-tailed P<.05 was considered significant. Logistic regression was used to adjust for confounding variables.
  
  
  METHODS
  The primary endpoint was clinical pregnancy. The secondary endpoints were E(2) dosage, endometrial thickness, fertilization, embryo quality, and rates of embryo cleavage, transfer, and implantation, positive beta-hCG, and biochemical, ectopic, and multiple pregnancy.
  
  
  RESULTS
  There was no statistically significant difference in clinical pregnancy rates (28.18% vs. 30.08%; OR 0.91 [0.49-1.67]; RR 1.07 [0.69-1.65]; adjusted OR 0.95 [0.51-1.78]). The mean E(2) dosage, endometrial thickness, fertilization rate, embryo score, embryo cleavage, number of embryos transferred, and rates of implantation, positive beta-hCG, and biochemical, ectopic, and multiple pregnancy were similar.
  
  
  CONCLUSIONS
  The prognosis with use of shared oocytes is similar to that with altruistic donors.
authors.affiliation: Assisted Conception Unit, Birmingham Women's Hospital, Birmingham, United Kingdom; University of Birmingham, Birmingham, United Kingdom. Electronic address: Olufunso.Oyesanya@kellogg.ox.ac.uk.
authors.forename: Olufunso A
authors.initials: OA
authors.lastname: Oyesanya
authors.affiliation: Assisted Conception Unit, Birmingham Women's Hospital, Birmingham, United Kingdom.
authors.forename: Olufemi
authors.initials: O
authors.lastname: Olufowobi
authors.affiliation: Assisted Conception Unit, Birmingham Women's Hospital, Birmingham, United Kingdom.
authors.forename: Wendy
authors.initials: W
authors.lastname: Ross
authors.affiliation: Assisted Conception Unit, Birmingham Women's Hospital, Birmingham, United Kingdom.
authors.forename: Khaldoun
authors.initials: K
authors.lastname: Sharif
authors.affiliation: Assisted Conception Unit, Birmingham Women's Hospital, Birmingham, United Kingdom; University of Birmingham, Birmingham, United Kingdom.
authors.forename: Masoud
authors.initials: M
authors.lastname: Afnan
mesh_terms: D000328:Adult; D015331:Cohort Studies; D004624:Embryo Transfer / Q000379:methods*; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D006785:Hospitals, University; D006801:Humans; D007247:Infertility, Female / Q000175:diagnosis / Q000628:therapy; D016015:Logistic Models; D008597:Menstrual Cycle / Q000502:physiology*; D018587:Oocyte Donation / Q000379:methods*; D009865:Oocytes / Q000502:physiology*; D011247:Pregnancy; D018873:Pregnancy Rate; D011379:Prognosis; D011446:Prospective Studies; D014019:Tissue Donors; D016896:Treatment Outcome